{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:38:13Z","timestamp":1770824293899,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12105-019-01117-y","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:02:32Z","timestamp":1583150552000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma in 2020: Where Are We Now and Where Are We Going?"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-1283","authenticated-orcid":false,"suffix":"Jr.","given":"James S.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"1117_CR1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1148\/rg.2019190007","volume":"39","author":"U Parvathaneni","year":"2019","unstructured":"Parvathaneni U, Lavertu P, Gibson MK, et al. Advances in diagnosis and multidisciplinary management of oropharyngeal squamous cell carcinoma: state of the art. Radiographics. 2019;39:2055\u201368.","journal-title":"Radiographics"},{"key":"1117_CR2","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.18.00684","volume":"36","author":"C Fakhry","year":"2018","unstructured":"Fakhry C, Lacchetti C, Rooper LM, et al. Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline Endorsement Of The College of American Pathologists Guideline. J Clin Oncol. 2018;36:3152\u201361.","journal-title":"J Clin Oncol."},{"key":"1117_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","volume":"142","author":"JS Lewis Jr","year":"2018","unstructured":"Lewis JS Jr, Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142:559\u201397.","journal-title":"Arch Pathol Lab Med."},{"key":"1117_CR4","first-page":"794","volume":"36","author":"H Zur Hausen","year":"1976","unstructured":"Zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res. 1976;36:794.","journal-title":"Cancer Res."},{"key":"1117_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"ML Gillison","year":"2000","unstructured":"Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709\u201320.","journal-title":"J Natl Cancer Inst."},{"key":"1117_CR6","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","volume":"33","author":"ML Gillison","year":"2015","unstructured":"Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235\u201342.","journal-title":"J Clin Oncol."},{"key":"1117_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fonc.2017.00129","volume":"7","author":"N Wurdemann","year":"2017","unstructured":"Wurdemann N, Wagner S, Sharma SJ, et al. Prognostic impact of AJCC\/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol. 2017;7:129.","journal-title":"Front Oncol."},{"key":"1117_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335.","journal-title":"N Engl J Med."},{"key":"1117_CR9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/bjc.2013.63","volume":"108","author":"AG Schache","year":"2013","unstructured":"Schache AG, Liloglou T, Risk JM, et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer. 2013;108:1332\u20139.","journal-title":"Br J Cancer."},{"key":"1117_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.01.002","volume":"54","author":"PP Sedghizadeh","year":"2016","unstructured":"Sedghizadeh PP, Billington WD, Paxton D, et al. Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. Oral Oncol. 2016;54:15\u201327.","journal-title":"Oral Oncol."},{"issue":"Suppl 1","key":"1117_CR11","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1007\/s12105-012-0369-0","volume":"6","author":"JS Lewis Jr","year":"2012","unstructured":"Lewis JS Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012;6(Suppl 1):S75\u201382.","journal-title":"Head Neck Pathol."},{"key":"1117_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cncr.27727","volume":"119","author":"KR Dahlstrom","year":"2013","unstructured":"Dahlstrom KR, Calzada G, Hanby JD, et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013;119:81\u20139.","journal-title":"Cancer"},{"key":"1117_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122\u201337.","journal-title":"CA Cancer J Clin."},{"key":"1117_CR14","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/PAS.0b013e318265fb2b","volume":"36","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6\/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874\u201382.","journal-title":"Am J Surg Pathol."},{"key":"1117_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.oraloncology.2016.02.008","volume":"55","author":"LM Rooper","year":"2016","unstructured":"Rooper LM, Gandhi M, Bishop JA, et al. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Oral Oncol. 2016;55:11\u20136.","journal-title":"Oral Oncol."},{"key":"1117_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/PAS.0b013e318220e59d","volume":"35","author":"OC Ukpo","year":"2011","unstructured":"Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6\/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343\u201350.","journal-title":"Am J Surg Pathol."},{"key":"1117_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.humpath.2018.04.006","volume":"78","author":"J Augustin","year":"2018","unstructured":"Augustin J, Outh-Gauer S, Mandavit M, et al. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas. Hum Pathol. 2018;78:63\u201371.","journal-title":"Hum Pathol."},{"key":"1117_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","volume":"36","author":"RC Jordan","year":"2012","unstructured":"Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36:945\u201354.","journal-title":"Am J Surg Pathol."},{"key":"1117_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ijc.27739","volume":"132","author":"G Gao","year":"2013","unstructured":"Gao G, Chernock RD, Gay HA, et al. A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer. 2013;132:882\u201390.","journal-title":"Int J Cancer."},{"issue":"Suppl 1","key":"1117_CR20","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1007\/s12105-012-0370-7","volume":"6","author":"M Robinson","year":"2012","unstructured":"Robinson M, Schache A, Sloan P, et al. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol. 2012;6(Suppl 1):S83\u201390.","journal-title":"Head Neck Pathol."},{"key":"1117_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/DAD.0000000000001289","volume":"41","author":"M Fujimoto","year":"2019","unstructured":"Fujimoto M, Matsuzaki I, Takahashi Y, et al. High-risk human papillomavirus E6\/E7 mRNA is rarely detected in nonanogenital cutaneous squamous cell carcinoma: an RNA in situ hybridization-based tissue microarray study. Am J Dermatopathol. 2019;41:205\u201310.","journal-title":"Am J Dermatopathol."},{"key":"1117_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000375148","volume":"59","author":"BJ Holmes","year":"2015","unstructured":"Holmes BJ, Maleki Z, Westra WH. The fidelity of p16 staining as a surrogate marker of human papillomavirus status in fine-needle aspirates and core biopsies of neck node metastases: implications for HPV testing protocols. Acta Cytol. 2015;59:97\u2013103.","journal-title":"Acta Cytol."},{"key":"1117_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/cncy.21600","volume":"123","author":"JB Jalaly","year":"2015","unstructured":"Jalaly JB, Lewis JS Jr, Collins BT, et al. Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx. Cancer Cytopathol. 2015;123:723\u201331.","journal-title":"Cancer Cytopathol."},{"key":"1117_CR24","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/cncy.22191","volume":"127","author":"DJ Buonocore","year":"2019","unstructured":"Buonocore DJ, Fowle E, Lin O, et al. Cytologic evaluation of p16 staining in head and neck squamous cell carcinoma in CytoLyt versus formalin-fixed material. Cancer Cytopathol. 2019;127:750\u20136.","journal-title":"Cancer Cytopathol"},{"key":"1117_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cncy.21372","volume":"122","author":"DA Kerr","year":"2014","unstructured":"Kerr DA, Pitman MB, Sweeney B, et al. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck. Cancer Cytopathol. 2014;122:167\u201374.","journal-title":"Cancer Cytopathol."},{"key":"1117_CR26","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jnci\/djy072","volume":"110","author":"AK Bryant","year":"2018","unstructured":"Bryant AK, Sojourner EJ, Vitzthum LK, et al. Prognostic role of p16 in nonoropharyngeal head and neck cancer. J Natl Cancer Inst. 2018;110:1393\u20139.","journal-title":"J Natl Cancer Inst."},{"key":"1117_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/1055-9965.EPI-14-1217","volume":"24","author":"KA Lang Kuhs","year":"2015","unstructured":"Lang Kuhs KA, Anantharaman D, Waterboer T, et al. Human papillomavirus 16 E6 antibodies in individuals without diagnosed cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2015;24:683\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"1117_CR28","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","volume":"25","author":"BS Chera","year":"2019","unstructured":"Chera BS, Kumar S, Beaty BT, et al. Rapid clearance profile of plasma circulating tumor HPV type 16 dna during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer. Clin Cancer Res. 2019;25:4682\u201390.","journal-title":"Clin Cancer Res."},{"key":"1117_CR29","doi-asserted-by":"publisher","first-page":"20170498","DOI":"10.1259\/bjr.20170498","volume":"91","author":"RT Leijenaar","year":"2018","unstructured":"Leijenaar RT, Bogowicz M, Jochems A, et al. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. Br J Radiol. 2018;91:20170498.","journal-title":"Br J Radiol."},{"key":"1117_CR30","doi-asserted-by":"publisher","first-page":"170077","DOI":"10.1038\/sdata.2017.77","volume":"4","author":"MMDACC Head","year":"2017","unstructured":"Head MMDACC, Neck Quantitative Imaging Working G. Matched computed tomography segmentation and demographic data for oropharyngeal cancer radiomics challenges. Sci Data. 2017;4:170077.","journal-title":"Sci Data."}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-019-01117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-019-01117-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-019-01117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:47:48Z","timestamp":1614646068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-019-01117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1007\/s12105-019-01117-y","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that he\/she has not conflict of interest as it relates to this research project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this retrospective data analysis involving human participants were in accordance with the ethical standards of the institutional review board, which did not require informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}